PITAVASTATIN MAGNESIUM

PITAVASTATIN MAGNESIUM was reported 59 times

These side effects are most commonly reported by patients taking PITAVASTATIN MAGNESIUM:

# Side effect Count
0 HEADACHE 6
1 DEATH 5
2 DYSPNOEA 5
3 HOSPITALISATION 5
4 PRODUCT DOSE OMISSION ISSUE 5
5 PRURITUS 5
6 PAIN 4
7 ARTHRALGIA 3
8 CARDIAC DEATH 3
9 CONSTIPATION 3
10 DIZZINESS 3
11 FALL 3
12 FATIGUE 3
13 MALAISE 3
14 MUSCLE SPASMS 3
15 MYALGIA 3
16 RASH 3
17 DIARRHOEA 2
18 FEELING ABNORMAL 2
19 HOT FLUSH 2
20 INTENTIONAL PRODUCT USE ISSUE 2
21 MEMORY IMPAIRMENT 2
22 MYOCARDIAL INFARCTION 2
23 PAIN IN EXTREMITY 2
24 SKIN BURNING SENSATION 2
25 WEIGHT DECREASED 2
26 WEIGHT INCREASED 2
27 ABDOMINAL DISTENSION 1
28 ABDOMINAL PAIN UPPER 1
29 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1
30 ADVERSE DRUG REACTION 1
31 ANGINA PECTORIS 1
32 ANTIPHOSPHOLIPID SYNDROME 1
33 APHTHOUS ULCER 1
34 ASPARTATE AMINOTRANSFERASE INCREASED 1
35 ASTHENIA 1
36 ASTHMA 1
37 ATRIAL FIBRILLATION 1
38 BLOOD CREATININE INCREASED 1
39 BLOOD GLUCOSE INCREASED 1
40 BLOOD PRESSURE DIASTOLIC INCREASED 1
41 BRONCHITIS 1
42 CARDIOMYOPATHY 1
43 CHEST DISCOMFORT 1
44 CHILLS 1
45 COAGULATION FACTOR V LEVEL ABNORMAL 1
46 CONDITION AGGRAVATED 1
47 COUGH 1
48 COVID-19 1
49 DECREASED APPETITE 1
50 DEPRESSED MOOD 1
51 DERMATITIS 1
52 DERMATITIS ATOPIC 1
53 DEVICE DEFECTIVE 1
54 DEVICE MALFUNCTION 1
55 DISCOMFORT 1
56 DRUG ERUPTION 1
57 DRUG HYPERSENSITIVITY 1
58 DRUG INEFFECTIVE 1
59 DRUG INTERACTION 1
60 DRUG INTOLERANCE 1
61 DYSKINESIA 1
62 DYSPHONIA 1
63 DYSURIA 1
64 ECZEMA 1
65 EPISTAXIS 1
66 ERYTHEMA MULTIFORME 1
67 EXFOLIATIVE RASH 1
68 EYE PRURITUS 1
69 FEELING HOT 1
70 FEELING JITTERY 1
71 FLATULENCE 1
72 FOOT FRACTURE 1
73 GASTROINTESTINAL INFLAMMATION 1
74 GENITAL PAIN 1
75 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
76 GRAFT VERSUS HOST DISEASE 1
77 HALLUCINATION 1
78 HEPATIC FIBROSIS MARKER INCREASED 1
79 HYPERSENSITIVITY 1
80 HYPOAESTHESIA 1
81 HYPOKALAEMIA 1
82 INFLUENZA LIKE ILLNESS 1
83 INJECTION SITE PAIN 1
84 INTENTIONAL PRODUCT MISUSE 1
85 LINEAR IGA DISEASE 1
86 LIP PAIN 1
87 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
88 LOW DENSITY LIPOPROTEIN INCREASED 1
89 LUPUS-LIKE SYNDROME 1
90 MENTAL DISORDER 1
91 MUSCLE ATROPHY 1
92 MUSCULOSKELETAL PAIN 1
93 NAUSEA 1
94 NIGHT SWEATS 1
95 OEDEMA 1
96 OEDEMA PERIPHERAL 1
97 OFF LABEL USE 1
98 ORAL CANDIDIASIS 1
99 ORAL PAIN 1
100 OROPHARYNGEAL ERYTHEMA 1
101 OROPHARYNGEAL PAIN 1
102 OXYGEN SATURATION DECREASED 1
103 PARAESTHESIA 1
104 PARANEOPLASTIC PEMPHIGUS 1
105 PERIPHERAL ISCHAEMIA 1
106 PERIPHERAL SWELLING 1
107 PNEUMONIA 1
108 POLLAKIURIA 1
109 POST PROCEDURAL HAEMORRHAGE 1
110 PRESCRIBED UNDERDOSE 1
111 PRODUCT PRESCRIBING ERROR 1
112 PRODUCT USE IN UNAPPROVED INDICATION 1
113 PYREXIA 1
114 PYURIA 1
115 RENAL DISORDER 1
116 RENAL IMPAIRMENT 1
117 RENAL PAIN 1
118 RESPIRATORY DISORDER 1
119 RHINORRHOEA 1
120 SINUS CONGESTION 1
121 SKIN DISORDER 1
122 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1
123 STEVENS-JOHNSON SYNDROME 1
124 SYSTEMIC LUPUS ERYTHEMATOSUS 1
125 TASTE DISORDER 1
126 THERAPY NON-RESPONDER 1
127 TINNITUS 1
128 TOXIC EPIDERMAL NECROLYSIS 1
129 TREMOR 1
130 UNEVALUABLE EVENT 1
131 URINE OUTPUT DECREASED 1
132 VOMITING 1
133 VULVOVAGINAL CANDIDIASIS 1
134 WOUND HAEMORRHAGE 1
135 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1